MSN: Researchers lead unprecedented genetic study of movement disorders
University of Cincinnati expands study to include Chilean patients
University of Cincinnati researchers are expanding a study to learn more about the genetic markers of movement disorders, a range of conditions affecting the nervous system that are increasingly being found to be caused by genetic mutations.
Luca Marsili, MD, PhD, adjunct instructor in the Department of Neurology and Rehabilitation Medicine in the UC College of Medicine, said the majority of research of the genetics of movement disorders to this point has been focused on European populations.
"There is a need to expand the knowledge to other populations from other ethnicities and ethnic groups,” Marsili said. “It's very helpful because we learn from the differences, particularly in the genetics.”
The expansion of the study stems from a new partnership between UC and the University of Chile.
Alberto Espay, MD, professor of neurology in the UC College of Medicine, director and endowed chair of the James J. and Joan A. Gardner Family Center for Parkinson's Disease at the UC Gardner Neuroscience Institute and a UC Health physician, told MSN the testing looks to discover genetic mutations that have already been documented as well as others that have not yet been identified.
"Part of the reason we want to do this, of course, is that we want to open up therapeutic pathways, and we couldn't if we don't know what the genetic abnormality is," Espay said. "The bottom line is that the slice of the pie for neurogenetic disorders for which a diagnosis is known is starting to increase."
Read the MSN article in Spanish.
Read the MSN article in English via Google Translate.
Dr. Espay was also featured on Mujer Latina Today's podcast Lorena Today to talk about the study. Listen to the podcast in Spanish.
Editor's note: Espay's quote pulled from MSN article translated from Spanish to English using Google Translate.
Featured photo at top courtesy of Unsplash.
Related Stories
Medscape: Skin adverse events rare after immunotherapy to treat...
April 17, 2024
Medscape highlighted University of Cincinnati research published in JAMA Dermatology that found skin adverse events were rare following immunotherapy treatments for certain skin cancers.
UC researchers develop new CPAP device
April 17, 2024
Researchers at the University of Cincinnati are developing a VortexPAP machine that takes advantage of vortex airflow technology. A preliminary clinical study with current CPAP users demonstrated that the VortexPAP can deliver the pressure levels that are used in the subjects’ CPAP therapy, but the mask is more comfortable to wear. It has a minimalistic design that is less intrusive and barely touches the patient’s face.
UC President Neville Pinto shares 2024 State of the University...
April 16, 2024
University of Cincinnati President Neville G. Pinto shared his 2024 Sate of the University address with the campus community on April 15.